IQAIFIQ AI Ltd.

About IQ AI Ltd. (IQAIF)

IQ AI Ltd. (IQAIF) is a Health Information Services company headquartered in St. Helier, Jersey whose shares trade over-the-counter on the Pink tier.

IQ-AI Limited focuses on advancing healthcare by developing and commercializing state-of-the-art medical software solutions and services. In March 2018, IQ-AI Ltd acquired Imaging Biometrics, LLC (IB), a Wisconsin USA-based medical imaging software company. In addition to providing regulatory consulting services, IB supplies medical technology solutions and has a strong neuroimaging product portfolio. IB's analytical solutions enable clinicians to better diagnose and treat disease with greater confidence. IB is the second acquisition made by IQ-AI in the medical imaging space after acquiring Stone Checker Software Ltd in 2017.

Products and services

IQ-AI Limited (IQAI), with offices in Jersey, has operations in Elm Grove, Wisconsin, USA (near Milwaukee) with its subsidiary Imaging Biometrics, LLC (IB). IB develops and distributes medical imaging software solutions for the healthcare industry. Founded in January 2007, IB's core suite of products are renowned for their accuracy and quantitative output when analyzing magnetic resonance (MR) and computed tomography (CT) images of neuro diseases such as brain tumors and stroke. The core application is based on over 25 years of research and development in the field of dynamic susceptibility contrast (DSC) imaging. The software product (IB Neuro) performs exclusive calculations that measure, among other things, blood volume and blood flow. These parameters are shown to have clinical application in the diagnosis, surgical guidance, and treatment monitoring of brain tumor patients. IB also offers unique services by assisting medical researchers and scientists in bringing new discoveries to market. These services included regulatory expertise for achieving both US FDA market clearance and CE mark approval. The overall product portfolio includes applications that extend beyond the neuro space.

IQAIF key facts

Ticker symbol

IQAIF

Market tier

Pink

Sector

Healthcare

Industry

Health Information Services

Headquarters

St. Helier, Jersey

Country of incorporation

JE

Year of incorporation

2017

Employees

4

Estimated market cap

$3.65M (as of May 12, 2025)

Shares outstanding

182,621,390

Reporting standard

International Reporting: LSE - London Stock Exchange

Audit status

Audited

Fiscal year end

12/31

Latest filing

Semi-Annual Report (Jun 30, 2023)

IQ AI Ltd. leadership

• Trevor Brown — CEO
• Michael James Schmainda — Executive Director
• Mark Anwyl — Other

Explore more: Health Information Services stocks · Healthcare sector · Pink stocks · OTC stocks starting with I